Cargando…
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
Intratumoral phenotypic heterogeneity has been described in many tumor types, where it can contribute to drug resistance and disease recurrence. We analyzed ductal and neuroendocrine markers in pancreatic ductal adenocarcinoma, revealing heterogeneous expression of the neuroendocrine marker Synaptop...
Autores principales: | Farrell, Amy S., Joly, Meghan Morrison, Allen-Petersen, Brittany L., Worth, Patrick J., Lanciault, Christian, Sauer, David, Link, Jason, Pelz, Carl, Heiser, Laura M., Morton, Jennifer P., Muthalagu, Nathiya, Hoffman, Megan T., Manning, Sara L., Pratt, Erica D., Kendsersky, Nicholas D., Egbukichi, Nkolika, Amery, Taylor S., Thoma, Mary C., Jenny, Zina P., Rhim, Andrew D., Murphy, Daniel J., Sansom, Owen J., Crawford, Howard C., Sheppard, Brett C., Sears, Rosalie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701042/ https://www.ncbi.nlm.nih.gov/pubmed/29170413 http://dx.doi.org/10.1038/s41467-017-01967-6 |
Ejemplares similares
-
Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma
por: Hinestrosa, Juan Pablo, et al.
Publicado: (2023) -
BIM's up first
por: Murphy, Daniel J., et al.
Publicado: (2014) -
Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma
por: Chen, Emerson Y., et al.
Publicado: (2023) -
Synchronous invasive ductal carcinoma in encapsulated papillary ductal carcinoma
por: Regan, J.P., et al.
Publicado: (2016) -
ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells
por: Langer, E M, et al.
Publicado: (2018)